Research and Markets (http://www.researchandmarkets.com/research/3e1fb3/analyzing_the_gene) has announced the addition of the "Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry" report to their offering. [More]

Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Pharmaceutical Market Access, Pricing, and Reimbursement News in the Second Quarter of 2009" to their offering. [More]

Drug approvals are taking just as long as they ever did despite increased expenditure on new information technology at the Food and drug Administration. So says a statistical analysis of approval intervals from 1997 to 2006, published in the International Journal of Electronic Healthcare. [More]

Research and Markets has announced the addition of the "South Africa Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. [More]

Medtipster, the company behind the new online healthcare search engine and price comparator Medtipster.com, is pleased to announce a new promotion to help Michigan residents save on their prescription costs. [More]

"A $112 million settlement involving alleged drug kickbacks that the Justice Dept. announced with the nation's largest nursing home pharmacy and a generic drug manufacturer on Nov. 3 is part of a wide-ranging investigation of suspected Medicaid fraud by the pharmaceutical industry," Business Week reports. "Critics say the continuing probe, which involves Johnson & Johnson (JNJ) and other major drugmakers, highlights what they describe as an industry practice of paying money to outfits that provide drugs to consumers, in return for preferential treatment." [More]

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with PharmaNet Development Group, Inc., a global drug development services company, that enables PharmaNet to offer Phase Forward’s InForm™ electronic data capture (EDC) solution to PharmaNet customers worldwide. [More]

AmerisourceBergen Corporation today reported that in its fiscal year 2009 fourth quarter ended September 30, 2009, diluted earnings per share were $0.44, a 22 percent increase, and revenue increased 9 percent to a record $18.7 billion. Earnings per share and other share-related data reflect the Company’s June 2009 two-for-one stock split. [More]

Research and Markets (http://www.researchandmarkets.com/research/051a60/india_pharmaceutic) has announced the addition of the "India Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. [More]

Reed Technology and Information Services Inc., a LexisNexis® business, today announced the introduction of LabelDataPlus™ – a comprehensive drug label database available on the Web for both industry and consumer use. LabelDataPlus offers more than 5,000 current and archived FDA-approved drug labels – the same drug information found on the National Library of Medicine’s DailyMed web site – combined with powerful search features that unlock the information contained in drug labels (package inserts). [More]

The Coalition for a Competitive Pharmaceutical Market (CCPM), its allied organizations, representing several hundred million Americans, join experts from the medical and research communities, economists and thought leaders appealing to Congress to fix the excessive 12-year market exclusivity and ever-greening provisions for biologics or drop it altogether. [More]

Health care lobbyists are on track to set new spending records this year, with some individual companies nearly doubling their investment compared to previous periods, USA Today reports. The Pharmaceutical Research and Manufacturers of America spent almost as much by September as it did in the entire year in 2008. America's Health Insurance Plans has spent $1 million more so far this year than over the same period last year (Schouten, 10/21). [More]

Schering-Plough Corporation (NYSE: SGP) today reported financial results for the 2009 third quarter. [More]

A cholera outbreak in Zimbabwe has infected more than 100, resulting in five deaths, state media said Tuesday, Reuters reports, "raising fears of a repeat of last year's epidemic that claimed more than 4,000 lives. [More]

Unions largely oppose the bill approved by the Senate Finance Committee Tuesday. [More]